mxf
☆    

Italy,
2014-03-13 21:52
(4115 d 08:21 ago)

Posting: # 12617
Views: 4,716
 

 incomplete data [🇷 for BE/BA]

Dear All,
after seeing other post in this forum, I would like to clear and point out the state of the art of incomplete data analysis. I haven't commercial softwares and usually work on R. Bear is a very good package, but it seems to be unable for performing analysis with incomplete dataset.

If possible, I would appreciate any possible suggestion about incomplete data anlaysis with R or other not commercial software.

Thank you at all and have patience for my terrible English!

Max
yjlee168
★★★
avatar
Homepage
Kaohsiung, Taiwan,
2014-03-18 11:17
(4110 d 18:56 ago)

@ mxf
Posting: # 12645
Views: 3,749
 

 incomplete data

Dear Max,

❝ […] I haven't commercial softwares and usually work on R. Bear is a very good package, but it seems to be unable for performing analysis with incomplete dataset.


If there is any appropriate statistic model for a incomplete crossover study design (I assume that it's your study design), it should be no problem to build this function into bear. BTW, I am thinking how to present the incomplete data in summary table. For instance, we require to list T/R values for pivotal parameters (such as Cmax and AUCs). If there is no T, then the T/R are all zero; If there is no R, oops! We will get all T/R as "inf"(inity) which is 'not a number (NaN)' in R. Please see this post by Helmut and others. In that post, Helmut got the same 90% CI for Cmax for "subject(sequence) fixed, n=24/23 (i.e., including the incomplete data)" and "subject(sequence) fixed, n=23/23 (without incomplete data)" using a commercial software.

❝ If possible, I would appreciate any possible suggestion about incomplete data analysis with R or other not commercial software.


yes, only if possible... Hope this can help.

All the best,
-- Yung-jin Lee
bear v2.9.2:- created by Hsin-ya Lee & Yung-jin Lee
Kaohsiung, Taiwan https://www.pkpd168.com/bear
Download link (updated) -> here
Dr_Dan
★★  

Germany,
2014-03-18 12:45
(4110 d 17:28 ago)

@ mxf
Posting: # 12649
Views: 3,635
 

 incomplete data

Dear Max
Although not written for BE studies guideline CPMP/EWP/1776/99 could give you some information. One approach would be to determine the highest and lowest possible concentration which still would lead to a positive study result and discuss these concentration in a sensitivity analysis. Unfortunately I am not a statistician and can not provide advice with regard to statistical analysis software.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan
mxf
☆    

Italy,
2014-03-26 18:58
(4102 d 11:14 ago)

@ Dr_Dan
Posting: # 12718
Views: 3,610
 

 incomplete data

Sorry for my delay, but I had a problem in logged in! :confused:

Thanks for all your suggestions. I will think something...

Max
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
44 visitors (0 registered, 44 guests [including 6 identified bots]).
Forum time: 07:13 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5